Singhal Singhal

Dr. Singhal Singhal

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Ibnosina Journal of Medicine and Biomedical Sciences
Verified
Journal Article
Open access
PDF file
SBSudhir Bhandari
Sudhir Bhandari
ASAjit Shaktawat
Ajit Shaktawat
ATAmit Tak
Amit Tak
BPBhoopendra Patel
Bhoopendra Patel
JSJyotsna Shukla
Jyotsna Shukla
ADAmitabh Dube
Amitabh Dube
Background: The triage of coronavirus-19 patients into various strata based on some prognostic indicator might prove a utilitarian strategy in the management of epidemic. The goal of health-care facilities is optimization of the use of medical resources. The present study aimed to develop a predictor model of mortality risk from routine hematologic parameters. Patients and Methods: In this retrospective case–control study, seventy survivors (n = 47) and nonsurvivors (n = 23) were enrolled who were laboratory-confirmed coronavirus disease 2019 (COVID-19) cases from SMS Medical College, Jaipur (Rajasthan, India). The clinical and routine blood profile of the survivors and nonsurvivors was recorded. A logistic regression model was fitted with step-wise method to the above dataset with dependent variable such as survivor or nonsurvivor and independent variables such as age, sex, symptoms, random blood glucose, and complete blood count. The best model was selected on the basis of Akaike information criterion. Results: It was observed that differential neutrophil count (%) and random blood sugar (RBS in mg/dL) are the statistically significant regressors (P < 0.05). The performance metrics of the model with 5-fold cross-validation showed area under the receiver operating characteristic curve, sensitivity, specificity, and validation accuracy to be 0.95, 90%, 92%, and 70%, respectively. The cutoff probability comes out at 0.30 for the outcome (nonsurvivor as success). Conclusion: The study concludes that differential neutrophil count and RBS levels can be used as early screening tools of mortality risk in COVID-19 patients and they assist in further patient management. Nil. Received: 25 May 2020 Accepted: 17 June 2020 Article published online: 07 July 2022 © 2020. The Libyan Authority of Scientific Research and Technologyand the Libyan Biotechnology Research Center. All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License,permitting copying and reproductionso long as the original work is given appropriate credit. Contents may not be used for commercial purposes, oradapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

2 February 2023 in Expert Review of Vaccines
Verified
Journal Article
Open access
GSGhanshyam Sethy
Ghanshyam Sethy
MCMike Nenani Chisema
Mike Nenani Chisema
LSLokesh Sharma
Lokesh Sharma
SSSinghal Singhal
Singhal Singhal
KJKrupal Joshi
Krupal Joshi
JPJohn Phuka
John Phuka
To boost COVID-19 vaccine uptake, an innovative ‘vaccinate my village’ (VMV) strategy using door-to-door vaccination by Health Surveillance Assistants (HSA) was adopted. In this study, we assessed ...

1 January 2015 in Indian Journal of Occupational and Environmental Medicine
Verified
Journal Article
Open access
PDF file
SSSinghal Singhal
Singhal Singhal
DDDeepakA Dwivedi
DeepakA Dwivedi
SASrinivasa Alasinga
Srinivasa Alasinga
VMVineet Kumar Malhotra
Vineet Kumar Malhotra
AKAtul Kotwal
Atul Kotwal
Indian J Occup Environ Med, Official publication of IOAH Indian Association of 0ccupational Health

18 July 2022 in Vaccine
Verified
Journal Article
Open access
GSGhanashyam Sethy
Ghanashyam Sethy
MCMike Chisema
Mike Chisema
LSLokesh Sharma
Lokesh Sharma
KJKrupal Joshi
Krupal Joshi
SSSinghal Singhal
Singhal Singhal
JPJohn Phuka
John Phuka
To establish the impact of “Covid-19 Vaccination express” (CVE) on vaccine uptake in Malawi Retrospective cross-sectional study to compare the daily vaccine administration rate in CVE and routine covid vaccination (RCV). RCV data was collected from March 2021 to October 2021. The data regarding CVE was collected from 5 November 2021 to 31 December 2021. Data was collected regarding (1) the total number and type of vaccine doses administered and (2) Demographic details like age, gender, occupation, presence of comorbidities, the first dose, or the second dose of the people who received a vaccine. From March-December 2021, a total of 1,866,623 COVID-19 vaccine doses were administered, out of which 1,290,145 doses were administered at a mean daily vaccination rate of 1854 (95% CI: 1292-2415) doses as a part of RCV, and 576,478 doses were administered at a mean daily vaccination rate of 3312 (95% CI: 2377-4248) doses as a part of CVE. Comparing the mean daily doses (Astra Zeneca, AZ doses 1 & 2) administered in the CVE and RCV showed that the mean daily doses of AZ vaccine administered were significantly higher in the CVE (p<0.05). CVE successfully increased the uptake of the Covid-19 vaccine.

1 January 2016 in Heart Views
Verified
Journal Article
Open access
PDF file
SSSinghal Singhal
Singhal Singhal
SBSrinivasa Alasinga Bhattachar
Srinivasa Alasinga Bhattachar
VPVivek Paliwal
Vivek Paliwal
VMVineet Kumar Malhotra
Vineet Kumar Malhotra
KAKalyani Addya
Kalyani Addya
AKAtul Kotwal
Atul Kotwal
Thrombotic events are relatively common in high altitude areas and known to occur in young soldiers working at high altitude without usual risk factors associated with thrombosis at sea-level. However, till now, cases with thrombotic events were reported only in lowlanders staying at high altitude. These two cases of pulmonary embolism demonstrate that thrombotic events can occur in highlanders after a prolonged stay at the extreme altitude.

30 April 2024 in Lung India
Verified
Journal Article
Open access
SSSinghal Singhal
Singhal Singhal
MGMohan Gurjar
Mohan Gurjar
JSJyoti Narayan Sahoo
Jyoti Narayan Sahoo
SSSai Saran
Sai Saran
RDRuchi Dua
Ruchi Dua
CKChandan Dev Singh Katoch
Chandan Dev Singh Katoch
Background: In recent years, a significant understanding of delivering optimal aerosol therapy and the availability of various drugs and devices have led to an increase in its use in clinical practice. There are only a few studies available regarding their use in critically ill patients from a few parts of the world. We aimed to study the practice pattern of aerosol therapy in critically ill patients from Indian intensive care units (ICUs). Methods: After ethical approval, this multi-centric prospective observational study was performed over a study period of four weeks. Newly admitted adult patients considered who had an artificial airway and/or ventilation (including non-invasive). Patients were followed up for the next 14 days or until ICU discharge/death (whichever came first) for details of each aerosol therapy, including ongoing respiratory support, drug type, and aerosol-generating device. Results: From the nine participating centers across India, 218 patients were enrolled. Of 218 enrolled patients, 72.48% received 4884 aerosols with 30.91 ± 27.15 (95%CI: 26.6-35.1) aerosols per patient over 1108 patient days. Approximately 62.7% during IMV, 30.2% during NIV, 2.3% in spontaneously breathing patients with an artificial airway during weaning, and 4.7% were given without an artificial airway after weaning or decannulation. In 59%, a single drug was used, and bronchodilators were the most frequent. The jet nebulizer was the most common, followed by the ultrasonic and vibrating mesh aerosol generator. The ventilator setting was changed in only 6.6% of the aerosol sessions with IMV and none with NIV. Conclusion: Aerosol therapy is frequently used with a wide variation in practices; bronchodilators are the most commonly used drugs, and jet nebulizers are the most widely used.